Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Immunology  |  Musculoskeletal  |  Rheumatology

Search Medical Condition
Please enter condition
Please choose location

Cutaneous Lupus Erythematosus Clinical Trials

A listing of Cutaneous Lupus Erythematosus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (30) clinical trials

If you or a family member have cutaneous lupus erythematosus (CLE) and/or systemic lupus erythematosus (SLE), you may want to consider the LILAC clinical research study. What is the purpose of the LILAC study? The purpose of the LILAC study is to learn if an investigational medication may effectively reduce ...

Phase N/A

People with Cutaneous Lupus Erythematosus are asked to participate in a research study being conducted by Northwell Health, North Shore University Hospital.

Phase N/A

If you or a family member have cutaneous lupus erythematosus (CLE) and/or systemic lupus erythematosus (SLE), you may want to consider the LILAC clinical research study. What is the purpose of the LILAC study? The purpose of the LILAC study is to learn if an investigational medication may effectively reduce ...

Phase N/A

A research study is evaluating an investigational medication for cutaneous lupus erythematosus (CLE), or lupus-specific skin lesions, in women. This research study may be an option if you: Are a female 18-75 years of age Have been diagnosed with moderate to severe CLE Have had an inadequate response or intolerance ...

Phase N/A

Local doctors are looking for people with Cutaneous Lupus for clinical research studies of an investigational medication. Compensation provided for time and travel!

Phase N/A

The overall purpose of the study is to assess the efficacy of three different doses of BI 655064 against placebo as add-on therapy to standard of care (SOC) treatment for active lupus nephritis in order to characterize the dose-response relationship within the therapeutic range, and select the target dose for ...

Phase

Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

There is an unmet need for new therapies to control inflammation in discoid lupus erythematosus (DLE). A significant proportion of DLE patients (with or without systemic lupus erythematosus (SLE)) are resistant to conventional therapies and DLE may be exacerbated by B cell depletion therapy.There is no clinical guideline or algorithm ...

Phase

Safety Tolerability Pharmacokinetics Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Patients

This study is designed to examine safety, tolerability, pharmacokinetics, pharmacodynamics and clinical effect of repeat dosing of GSK2646264 in patients with subacute and chronic cutaneous lupus erythematosus (CLE) lesions and in acute CLE like lesions induced by photoprovocation (PV). Current study is two group study. In Group A, Patients with ...

Phase

Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

The primary purpose of the study is to evaluate the efficacy of BIIB059 in reducing disease activity in participants with systemic lupus erythematosus (SLE) with active cutaneous manifestations and joint involvement (Part A), and in participants with active cutaneous lupus erythematosus (CLE) (Subacute cutaneous lupus erythematosus (SCLE) or chronic CLE, ...

Phase

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Study subjects will receive low dose (20 J/cm2) UVA1 phototherapy treatment three times per week for 10 weeks. Each treatment will take less than 30 minutes. This period will be followed by an eight-week observation phase to assess longer term effects of the treatment. Patients will be assessed for disease ...

Phase N/A